Hepatic Lymph Nodes as a Follow-up Factor in Primary Biliary Cirrhosis: An Ultrasound Study

1995 ◽  
Vol 30 (10) ◽  
pp. 1036-1040 ◽  
Author(s):  
K. Lyttkens ◽  
H. Prytz ◽  
L. Forsberg ◽  
I. Hägerstrand
Keyword(s):  
Primary Biliary Cirrhosis ◽  
Lymph Nodes ◽  
Biliary Cirrhosis ◽  
Ultrasound Study

A case of primary biliary cirrhosis with sarcoid reaction in the regional lymph nodes after surgery of early gastric cancer

Kanzo ◽  
2005 ◽  
Vol 46 (7) ◽  
pp. 437-442 ◽  
Author(s):  
Tadashi YOSHIDA ◽  
Atsushi NAGASAKA ◽  
Yayoi OGAWA ◽  
Syuji NISHIKAWA ◽  
Akifumi HIGUCHI
Keyword(s):  
Gastric Cancer ◽  
Early Gastric Cancer ◽  
Primary Biliary Cirrhosis ◽  
Lymph Nodes ◽  
Biliary Cirrhosis ◽  
Regional Lymph Nodes ◽  
Sarcoid Reaction

922 INCREASED CANCER RISK IN A LARGE POPULATION-BASED COHORT OF PATIENTS WITH PRIMARY BILIARY CIRRHOSIS: FOLLOW-UP FOR UP TO 36 YEARS

2013 ◽  
Vol 58 ◽  
pp. S380
Author(s):  
K. Boonstra ◽  
P.H. Stadhouders ◽  
H.A.R.E. Tuynman ◽  
A.C. Poen ◽  
C.M.J. van Nieuwkerk ◽  
...  
Keyword(s):  
Primary Biliary Cirrhosis ◽  
Cancer Risk ◽  
Large Population ◽  
Population Based ◽  
Biliary Cirrhosis

Primary Biliary Cirrhosis

2015 ◽  
Author(s):  
Daniel S. Pratt ◽  
Lindsay Y. King
Keyword(s):  
Differential Diagnosis ◽  
Liver Disease ◽  
Primary Biliary Cirrhosis ◽  
Liver Diseases ◽  
American Association ◽  
Cholestatic Liver Disease ◽  
Biliary Cirrhosis ◽  
Common Cause ◽  
History Of

Primary biliary cirrhosis (PBC) is a progressive autoimmune disease of the liver. It is the most common cause of chronic intrahepatic cholestatic liver disease in adults. This review addresses the epidemiology, etiology and genetics, pathophysiology and pathogenesis, diagnosis, differential diagnosis, treatment, complications, and prognosis of PBC. Figures show the pathogenesis and natural history of PBC and histologic features of the four stages of PBC. Tables list diagnostic criteria for PBC via the American Association for the Study of Liver Diseases, differential diagnosis for PBC, medications used to treat PBC, secondary therapy for PBC, and follow-up of patients with PBC. This review contains 2 highly rendered figures, 5 tables, and 45 references.

scholarly journals Serial Analysis of Antimitochondrial Antibody in Patients with Primary Biliary Cirrhosis

2004 ◽  
Vol 11 (2) ◽  
pp. 129-133 ◽  
Author(s):  
Gordon D. Benson ◽  
Kentaro Kikuchi ◽  
Hiroshi Miyakawa ◽  
Atsushi Tanaka ◽  
Mitchell R. Watnik ◽  
...  
Keyword(s):  
Primary Biliary Cirrhosis ◽  
Age Of Onset ◽  
Biliary Cirrhosis ◽  
Younger Patients ◽  
Serologic Marker ◽  
Dependent Change ◽  
Time Dependent Change ◽  
Specific Igg ◽  
The Individual

Antimitochondrial antibodies (AMAs) are the classic serologic marker in primary biliary cirrhosis (PBC). However, there have been only limited attempts to study changes in titer or isotype analysis of such AMAs in patients followed for long periods of timeWe took advantage of stored sera from well-characterized patients with PBC followed for a period of 7-28 years (mean duration of 13.5 years). Immunoblot and enzyme-linked immunosorbant assays were performed against PDC-E2, BCOADC-E2 and OGDC-E2 as well as isotype analysis of antigen-specific IgG, IgA and IgM antibodies against each of these mitochondrial autoantigens. Sera were analyzed for total IgG, IgA and IgM by radial immunodiffusion. The sera titer of AMAs was significantly higher in younger patients with PBC. Indeed, age of onset of clinical PBC was a significant predictor for the highest values of sera AMAs. In contrast, the AMA titer did not significantly change over time in this prolonged longitudinal study. The total sera levels of the individual immunoglobulins did not show a time-dependent change, when based on age of onset of the disease. Higher titers of AMAs were noted in the younger patients. Furthermore, despite this long follow-up, there was no evidence for a significant change in AMA levels; also, levels were not influenced by drug therapy used during the period of observation.

146 PROGNOSIS OF 375 URSODEOXYCHOLIC ACID-TREATED PATIENTS WITH PRIMARY BILIARY CIRRHOSIS. A FOLLOW-UP TO 17 YRS

2008 ◽  
Vol 48 ◽  
pp. S63
Author(s):  
E.M. Kuiper ◽  
B.E. Hansen ◽  
R.A. de Vries ◽  
J.W. den Ouden-Muller ◽  
K.J. van Erpecum ◽  
...  
Keyword(s):  
Primary Biliary Cirrhosis ◽  
Ursodeoxycholic Acid ◽  
Biliary Cirrhosis

scholarly journals Prolonged Follow-Up of Patients in the U.S. Multicenter Trial of Ursodeoxycholic Acid for Primary Biliary Cirrhosis

2004 ◽  
Vol 99 (2) ◽  
pp. 264-268 ◽  
Author(s):  
Burton Combes ◽  
Velimir A Luketic ◽  
Marion G Peters ◽  
Rowen K Zetterman ◽  
Guadalupe Garcia-Tsao ◽  
...  
Keyword(s):  
Primary Biliary Cirrhosis ◽  
Ursodeoxycholic Acid ◽  
Multicenter Trial ◽  
Biliary Cirrhosis ◽  
The U.S

The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: Results of a 9year follow-up

2010 ◽  
Vol 53 (5) ◽  
pp. 911-917 ◽  
Author(s):  
David E. Jones ◽  
Ahmad Al-Rifai ◽  
James Frith ◽  
Imran Patanwala ◽  
Julia L. Newton
Keyword(s):  
Primary Biliary Cirrhosis ◽  
Biliary Cirrhosis ◽  
Independent Effects
Sign in / Sign up

Export Citation Format

Share Document